These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 13910648)
1. In vitro studies on a new urease-blocking agent, N-(3-chloromercury-2-methoxypropyl)-5-methyl-3-isoxazole carboxamide. SENECA H; LATTIMER JK; PEER P; NALLY R Antibiot Chemother (Northfield); 1961 Nov; 11():715-23. PubMed ID: 13910648 [No Abstract] [Full Text] [Related]
2. Drug-resistant bacteria made drug-susceptible by enzyme inhibitors. LATTIMER JK; SENECA H; ZINSSER HH; DONOVAN JT JAMA; 1961 Nov; 178():764-6. PubMed ID: 14462711 [No Abstract] [Full Text] [Related]
3. Azomethines, isoxazole, N-substituted pyrazoles and pyrimidine containing curcumin derivatives: Urease inhibition and molecular modeling studies. Ahmed M; Qadir MA; Hameed A; Arshad MN; Asiri AM; Muddassar M Biochem Biophys Res Commun; 2017 Aug; 490(2):434-440. PubMed ID: 28623137 [TBL] [Abstract][Full Text] [Related]
4. [Synthesis and study of the bacteriostatic activity of the hydroxamic acid derivatives of isoxazole]. CARADONA C; STEIN ML Farmaco Sci; 1960 Oct; 15():647-54. PubMed ID: 14448601 [No Abstract] [Full Text] [Related]
5. [Chemotherapy of resistant infections by inhibition of bacterial urease]. SENECA H Bull Acad Natl Med; 1962 Feb 20-27; 146():146-8. PubMed ID: 13910655 [No Abstract] [Full Text] [Related]
6. Inhibition of urease by lead acetate. BAHADUR K; CHANDRA V Enzymologia; 1959 Jul; 20():355-8. PubMed ID: 13795786 [No Abstract] [Full Text] [Related]
7. Changes in bacterial enzyme patterns, drug susceptibility and chemotherapy through enzyme blocking agents. SENECA H; LATTIMER JK; ZINSSER JJ; DONOVAN JT; PEER P; STUART PH Trans Am Assoc Genitourin Surg; 1961; 53():188-95. PubMed ID: 13910650 [No Abstract] [Full Text] [Related]
8. Synthesis and biological evaluation of novel series of aminopyrimidine derivatives as urease inhibitors and antimicrobial agents. Adsul LK; Bandgar BP; Chavan HV; Jalde SS; Dhakane VD; Shirfule AL J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1316-23. PubMed ID: 23230954 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro urease inhibitory activity of N,N'-disubstituted thioureas. Khan KM; Naz F; Taha M; Khan A; Perveen S; Choudhary MI; Voelter W Eur J Med Chem; 2014 Mar; 74():314-23. PubMed ID: 24486414 [TBL] [Abstract][Full Text] [Related]
10. Inhibitors of bacterial urease: microbiological considerations on hydroxyurea influenza virus. Perrone G; Ferrari C; Arghittu M Boll Ist Sieroter Milan; 1982; 61(6):513-5. PubMed ID: 6765400 [TBL] [Abstract][Full Text] [Related]
11. Ferrocene-based guanidine derivatives: in vitro antimicrobial, DNA binding and docking supported urease inhibition studies. Gul R; Rauf MK; Badshah A; Azam SS; Tahir MN; Khan A Eur J Med Chem; 2014 Oct; 85():438-49. PubMed ID: 25108360 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, biological assay in vitro and molecular docking studies of new Schiff base derivatives as potential urease inhibitors. Aslam MA; Mahmood SU; Shahid M; Saeed A; Iqbal J Eur J Med Chem; 2011 Nov; 46(11):5473-9. PubMed ID: 21981981 [TBL] [Abstract][Full Text] [Related]
13. Plant-Derived Urease Inhibitors as Alternative Chemotherapeutic Agents. Hassan ST; Žemlička M Arch Pharm (Weinheim); 2016 Jul; 349(7):507-22. PubMed ID: 27244041 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, molecular docking, anti-Proteus mirabilis and urease inhibition of new fluoroquinolone carboxylic acid derivatives. Abdullah MA; Abuo-Rahma GE; Abdelhafez EM; Hassan HA; Abd El-Baky RM Bioorg Chem; 2017 Feb; 70():1-11. PubMed ID: 27908539 [TBL] [Abstract][Full Text] [Related]